New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—
Older periods Sep '23 Mar '24 Sep '24 Sep '25
ROE

+7 more TTM periods

1.55% — — —
ROA
1.45% — — —
Return on Tangible Assets
(11.57%) — — —
Free Cash Flow per Share
(0.32) — (1,125.07) (34.08)
Free Cash Flow
(2.48) (5.33) (6.30) (8.08)
Other line items
Cash ROIC
(2,807.26%) 52.25% (891.15%) (42.37%)
Operating CF/Net income
(1.34) — — —
Operating CF per Share
(0.32) — (1,125.07) (34.08)
Capex per Share
0.00 — 0.00 0.00

Fold the line items

Columns are period end dates